BBI insider filings

Brickell Biotech, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-05-17. Screen BBI transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for BBI between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Brickell Biotech, Inc.

FiledFormInsiderReported transactionsSource
2022-05-174VERU DENNISON T — DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-05-174SAMANT VIJAY B — DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-05-174LYONS GARY A — DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-05-174HARDY REGINALD L — CHAIRMAN OF THE BOARD, DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-05-094Chadha Deepak — Chief Research & Dev. OfficerGrant/award (A): 325,000 (derivative) @ $0EDGAR
2022-05-094Breton Jose — Chief Accounting OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-05-094Brown Robert Busard — Chief Executive Officer, DirectorGrant/award (A): 1,100,000 (derivative) @ $0EDGAR
2022-05-094Sklawer Andrew D — COO and SecretaryGrant/award (A): 450,000 (derivative) @ $0EDGAR
2022-05-094McAvoy David R. — General Counsel and CCOGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-05-094Luchi Monica E. — Chief Medical OfficerGrant/award (A): 325,000 (derivative) @ $0EDGAR
2022-05-094MARCHIO ALBERT N II — Chief Financial OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-02-254HARDY REGINALD L — CHAIRMAN OF THE BOARD, DirectorTax withholding (F): 15,180 @ $0.23EDGAR
2021-09-034Luchi Monica E. — Chief Medical OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2021-07-274McAvoy David R. — General Counsel and CCOPurchase (P): 18,124 @ $0.67EDGAR
2021-07-274HARDY REGINALD L — CHAIRMAN OF THE BOARD, DirectorPurchase (P): 100,000 @ $0.66 · Purchase (P): 100,000 @ $0.67EDGAR
2021-06-144Chadha Deepak — Chief Research & Dev. OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2021-06-144Breton Jose — Chief Accounting OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2021-06-144Brown Robert Busard — Chief Executive Officer, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2021-06-144Sklawer Andrew D — COO and SecretaryGrant/award (A): 250,000 (derivative) @ $0EDGAR
2021-06-144McAvoy David R. — General Counsel and CCOGrant/award (A): 200,000 (derivative) @ $0EDGAR
2021-06-144VERU DENNISON T — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-144SAMANT VIJAY B — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-144MARCHIO ALBERT N II — Chief Financial OfficerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-144LYONS GARY A — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-144HARDY REGINALD L — CHAIRMAN OF THE BOARD, DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-05-194Chadha Deepak — Chief Research & Dev. OfficerPurchase (P): 2,700 @ $0.82 · Purchase (P): 12,500 @ $0.83EDGAR
2021-05-194Sklawer Andrew D — COO and SecretaryPurchase (P): 15,375 @ $0.80EDGAR
2021-05-194McAvoy David R. — General Counsel and CCOPurchase (P): 18,622 @ $0.80 · Purchase (P): 7,980 @ $0.80EDGAR
2021-03-174Chadha Deepak — Chief Research & Dev. OfficerOption exercise (M): 25,000 · Tax withholding (F): 8,750 @ $1.14 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-03-174Breton Jose — Chief Accounting OfficerOption exercise (M): 15,000 · Tax withholding (F): 5,250 @ $1.14 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2021-03-174Brown Robert Busard — Chief Executive Officer, DirectorPurchase (P): 100,000 @ $1.18EDGAR
2021-03-174Sklawer Andrew D — COO and SecretaryOption exercise (M): 20,000 · Tax withholding (F): 7,000 @ $1.14 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2021-03-174McAvoy David R. — General Counsel and CCOOption exercise (M): 25,000 · Tax withholding (F): 8,750 @ $1.14 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2021-01-054SAMANT VIJAY B — DirectorTax withholding (F): 4,408 @ $0.78EDGAR
2021-01-054LYONS GARY A — DirectorTax withholding (F): 5,967 @ $0.78EDGAR
2021-01-054HARDY REGINALD L — Chairman of the Board, DirectorTax withholding (F): 4,873 @ $0.78 · Grant/award (A): 47,435 @ $0.78EDGAR
2020-09-214McAvoy David R. — General Counsel and CCOPurchase (P): 16,526 @ $0.83 · Purchase (P): 6,000 @ $0.84EDGAR
2020-09-174McAvoy David R. — General Counsel and CCOGrant/award (A): 350,000 (derivative) @ $0EDGAR
2020-09-174VERU DENNISON T — DirectorGift (G): 19,642 @ $0 · Grant/award (A): 13,580 @ $0.81 · Purchase (P): 15,355 @ $0.81 · Purchase (P): 14,645 @ $0.80 · Gift (G): 19,642 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-174SAMANT VIJAY B — DirectorGrant/award (A): 10,493 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-174LYONS GARY A — DirectorGrant/award (A): 11,934 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-174HARDY REGINALD L — Chairman of the Board, DirectorGrant/award (A): 15,226 @ $0.81 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2020-09-164Chadha Deepak — Chief Research & Dev. OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2020-09-164Breton Jose — Chief Accounting OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2020-09-164Brown Robert Busard — Chief Executive Officer, DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2020-09-164Sklawer Andrew D — COO and SecretaryGrant/award (A): 450,000 (derivative) @ $0EDGAR
2020-09-024VERU DENNISON T — DirectorOption exercise (M): 788 · Option exercise (M): 788 (derivative) @ $0EDGAR
2020-09-024SAMANT VIJAY B — DirectorOption exercise (M): 609 · Tax withholding (F): 256 @ $0.94 · Tax withholding (F): 6,375 @ $0.94 · Option exercise (M): 609 (derivative) @ $0EDGAR
2020-09-024LYONS GARY A — DirectorOption exercise (M): 692 · Tax withholding (F): 346 @ $0.94 · Tax withholding (F): 8,631 @ $0.94 · Option exercise (M): 692 (derivative) @ $0EDGAR
2020-09-024HARDY REGINALD L — Chairman of the Board, DirectorOption exercise (M): 883 · Tax withholding (F): 283 @ $0.94 · Tax withholding (F): 7,048 @ $0.94 · Option exercise (M): 883 (derivative) @ $0EDGAR

Recent 8-K events — Brickell Biotech, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-03-078-K1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-168-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-038-K1.02 — Termination of a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-278-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-158-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-158-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-018-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-178-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BBI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs